Exact Mass: 323.15213560000007
Exact Mass Matches: 323.15213560000007
Found 500 metabolites which its exact mass value is equals to given mass value 323.15213560000007,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Bialaphos
C11H22N3O6P (323.12461620000005)
A tripeptide comprising one L-phosphinothricyl and two L-alanyl units joined in sequence. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
FLUTOLANIL
CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4349; ORIGINAL_PRECURSOR_SCAN_NO 4346 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4226; ORIGINAL_PRECURSOR_SCAN_NO 4222 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9058; ORIGINAL_PRECURSOR_SCAN_NO 9056 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9153; ORIGINAL_PRECURSOR_SCAN_NO 9152 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4243; ORIGINAL_PRECURSOR_SCAN_NO 4241 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4249; ORIGINAL_PRECURSOR_SCAN_NO 4247 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9072; ORIGINAL_PRECURSOR_SCAN_NO 9070 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9189; ORIGINAL_PRECURSOR_SCAN_NO 9186 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4277; ORIGINAL_PRECURSOR_SCAN_NO 4275 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9107; ORIGINAL_PRECURSOR_SCAN_NO 9105 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4271; ORIGINAL_PRECURSOR_SCAN_NO 4268 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9124; ORIGINAL_PRECURSOR_SCAN_NO 9123
stylopine
C19H17NO4 (323.11575220000003)
Acremoauxin A
C16H21NO6 (323.13688060000004)
An indolyl carboxylate ester obtained by formal condensation of one of the primary hydroxy groups of D-arabinitol with the carboxy group of (2R)-2-(indol-3-yl)propanoic acid.
Rutacridone epoxide
C19H17NO4 (323.11575220000003)
Rutacridone epoxide is an alkaloid from roots and callus tissue cultures of Ruta graveolens (rue). Alkaloid from roots and callus tissue cultures of Ruta graveolens (rue).
Alloxydim
L-4-Hydroxyphenylglycyl-L-arginine
C14H21N5O4 (323.15934660000005)
Rucaparib
C19H18FN3O (323.14338300000003)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
Pararosaniline Hydrochloride
D004396 - Coloring Agents > D012394 - Rosaniline Dyes D005404 - Fixatives
Naftifine hydrochloride
C21H22ClN (323.14406820000005)
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Senicapoc
C20H15F2NO (323.11216440000004)
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Cyproheptadine hydrochloride
C21H22ClN (323.14406820000005)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D003879 - Dermatologic Agents > D000982 - Antipruritics D005765 - Gastrointestinal Agents D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cyproheptadine hydrochloride is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders[1][2].
Gliclazide
C15H21N3O3S (323.13035560000003)
Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic β cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Gliclazide has been shown to decrease fasting plasma glucose, postprandial blood glucose and glycosolated hemoglobin (HbA1c) levels (reflective of the last 8-10 weeks of glucose control). Gliclazide is extensively metabolized by the liver; its metabolites are excreted in both urine (60-70\\%) and feces (10-20\\%). A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas D007004 - Hypoglycemic Agents
(S)-Neolitsine
C19H17NO4 (323.11575220000003)
(S)-Neolitsine is found in herbs and spices. (S)-Neolitsine is an alkaloid from the leaves of Laurus nobilis (bay laurel).
N-Methoxycarbonylanonaine
C19H17NO4 (323.11575220000003)
N-Methoxycarbonylanonaine is found in alcoholic beverages. N-Methoxycarbonylanonaine is an alkaloid from fresh unripe fruits of Rollinia mucosa (biriba). Alkaloid from fresh unripe fruits of Rollinia mucosa (biriba). N-Methoxycarbonylanonaine is found in cherimoya, alcoholic beverages, and fruits.
Mukonicine
C20H21NO3 (323.15213560000007)
Mukonicine is found in herbs and spices. Mukonicine is an alkaloid from the leaves of Murraya koenigii (curry leaf tree
Gravacridonol
C19H17NO4 (323.11575220000003)
Gravacridonol is found in herbs and spices. Gravacridonol is an alkaloid from Ruta graveolens (rue). Alkaloid from Ruta graveolens (rue). Gravacridonol is found in herbs and spices.
Koenigicine
C20H21NO3 (323.15213560000007)
Koenigicine is found in herbs and spices. Koenigicine is an alkaloid from the leaves of Murraya koenigii (curryleaf tree
N-Monodemethylolopatadine
C20H21NO3 (323.15213560000007)
N-Monodemethylolopatadine is a metabolite of olopatadine. Olopatadine hydrochloride is an antihistamine (as well as anticholinergic) and mast cell stabilizer, sold as a prescription eye drop (0.2\\% solution, Pataday, manufactured by Alcon). It is used to treat itching associated with allergic conjunctivitis. Olopatadine hydrochloride 0.1\\% is sold as Patanol (or Opatanol in some countries). A nasal spray formulation is sold as Patanase, which was approved by the FDA on April 15, 2008. (Wikipedia)
(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine
(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is an acylcarnitine. More specifically, it is an (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
7-[(2-Benzyl-3-sulfanylpropanoyl)amino]heptanoic acid
C17H25NO3S (323.15550600000006)
Bialaphos
C11H22N3O6P (323.12461620000005)
Cyamemazine
C19H21N3S (323.14561060000005)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Cyamemazine is a neuroleptic agent that contains the phenothiazine chromophore. Cyamemazine is often used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki of 12 nM), 5-HT2A (Ki = 1.5 nM) and 5-HT2C (Ki of 75 nM) receptors antagonist with antipsychotic activity[1][2].
Dehydromonocrotaline
C16H21NO6 (323.13688060000004)
pyroglutamyl-histidyl-glycine
Rubraca
C19H18FN3O (323.14338300000003)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
Senicapoc
C20H15F2NO (323.11216440000004)
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Tetrahydrocoptisine
C19H17NO4 (323.11575220000003)
(±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2]. (±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2].
Tetrahydrocoptisine
C19H17NO4 (323.11575220000003)
Stylopine is a natural product found in Fumaria capreolata, Fumaria muralis, and other organisms with data available. (±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2]. (±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2].
Alanyl-2-(1,1-dimethyl-2-propenyl)dehydrotryptophan anhydride
Cyamemazine
C19H21N3S (323.14561060000005)
N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Cyamemazine is a neuroleptic agent that contains the phenothiazine chromophore. Cyamemazine is often used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki of 12 nM), 5-HT2A (Ki = 1.5 nM) and 5-HT2C (Ki of 75 nM) receptors antagonist with antipsychotic activity[1][2].
5HPP-33
C20H21NO3 (323.15213560000007)
CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5211 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5213 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5254; ORIGINAL_PRECURSOR_SCAN_NO 5252 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5226; ORIGINAL_PRECURSOR_SCAN_NO 5223 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5314; ORIGINAL_PRECURSOR_SCAN_NO 5312 ORIGINAL_ACQUISITION_NO 5234; CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5234; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9749; ORIGINAL_PRECURSOR_SCAN_NO 9744 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9783; ORIGINAL_PRECURSOR_SCAN_NO 9781 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9807; ORIGINAL_PRECURSOR_SCAN_NO 9805 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9830; ORIGINAL_PRECURSOR_SCAN_NO 9826 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9801; ORIGINAL_PRECURSOR_SCAN_NO 9798 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9831; ORIGINAL_PRECURSOR_SCAN_NO 9828
Dimefline HCL
C20H21NO3 (323.15213560000007)
R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant
2-[6-(diethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol
C14H21N5O4 (323.15934660000005)
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.710 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.712 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.707 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.708
TEB_M324b *
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2504
TEB_M324c
CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2505
12xi-hydroxy-14xi-methyl-(13xiH,15xiH)-15,20-dihydro-18,21-dinor-senecionane-11,16-dione|Crotananin|crotananine
Methoxy,Ac-2-(4-Hydroxyphenyl)-1-methyl-4(1H)-quinolinone6-
C19H17NO4 (323.11575220000003)
(+-)-1,2,10,11-Bismethylendioxyaporphin|(+-)-N-methyl-hernovine|(+-)-N-methyl-ovigerine|7-methyl-6,7,7a,8-tetrahydro-5H-[1,3]dioxolo[4,5:4,5]benzo[1,2,3-de][1,3]dioxolo[4,5:5,6]benzo[1,2-g]quinoline|N-Methyl-ovigerin|N-Methylovigerin
C19H17NO4 (323.11575220000003)
2-(3-methoxycarbonyl-propyl) gardenamide A|genipamide
C16H21NO6 (323.13688060000004)
5-hydroxynoracronycine
C19H17NO4 (323.11575220000003)
A natural product found in Citropsis articulata.
7-hydroxynoracronycine|9-hydroxynoracronycine
C19H17NO4 (323.11575220000003)
6-hydroxynoracronycine|citropsine A
C19H17NO4 (323.11575220000003)
3-(4-methoxy-3-methyl-2-oxo-2H-pyran-6-yl)butyl pyroglutamate
C16H21NO6 (323.13688060000004)
8-(4-O-methyl-alpha-rhamnopyranosyloxy)-3,4-dihydroquinolin-2(1H)-one
C16H21NO6 (323.13688060000004)
2,10-dimethoxy-7-hydroxy-aporphine
C19H17NO4 (323.11575220000003)
3-O-methylglycocitrine-II|O3-Me-Glycocitrine II
C20H21NO3 (323.15213560000007)
1-Hydoxy-3-methoxy-2-(3-methyl-2-butenyl)-10-methylacridone|1-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)-N-methylacridan-9-one
C20H21NO3 (323.15213560000007)
2-amino-9-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-3H-purin-6-one
Diphenylmethyl ester-Clavam-2-carboxylate
C19H17NO4 (323.11575220000003)
(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)Propanoic acid
C14H21N5O4 (323.15934660000005)
piperidolate
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Piperidolate is an antimuscarinic, inhibits intestinal cramp induced by acetylcholine (rats and dogs).
n-acetylneuraminic acid methyl ester
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.052 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054
Ritodrine hydrochloride
C17H22ClNO3 (323.1288132000001)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Ritodrine (DU21220) hydrochloride is a potent and orally active β-adrenergic agonist. Ritodrine hydrochloride decreases preterm delivery and uterine contraction. Ritodrine hydrochloride has the potential for the research of preterm labor[1][2].
(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione
C17H17N5O2_3-(1H-Imidazol-4-ylmethyl)-6-(1H-indol-3-ylmethyl)-2,5-piperazinedione
gliclazide
C15H21N3O3S (323.13035560000003)
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas D007004 - Hypoglycemic Agents
(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based: Match]
(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based on: CCMSLIB00000845126]
CP-457920
C18H17N3O3 (323.12698520000004)
CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4233; ORIGINAL_PRECURSOR_SCAN_NO 4230 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4258; ORIGINAL_PRECURSOR_SCAN_NO 4256 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4255; ORIGINAL_PRECURSOR_SCAN_NO 4253 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4244; ORIGINAL_PRECURSOR_SCAN_NO 4242 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4263; ORIGINAL_PRECURSOR_SCAN_NO 4259 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8818; ORIGINAL_PRECURSOR_SCAN_NO 8816 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8814; ORIGINAL_PRECURSOR_SCAN_NO 8811 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8832; ORIGINAL_PRECURSOR_SCAN_NO 8830 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8850; ORIGINAL_PRECURSOR_SCAN_NO 8845 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8851; ORIGINAL_PRECURSOR_SCAN_NO 8850 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8856; ORIGINAL_PRECURSOR_SCAN_NO 8854
3-Pyrrolidineacetic acid, 1-ethyl-5-oxo-4,4-diphenyl- (9CI)
C20H21NO3 (323.15213560000007)
2H-1-Benzopyran-2-one, 3-[1-(4-aminophenyl)-3-oxobutyl]-4-hydroxy-, (S)- (Acenocoumarol metabolite)
C19H17NO4 (323.11575220000003)
Kenidine
C20H21NO3 (323.15213560000007)
Mukonicine
C20H21NO3 (323.15213560000007)
Neolitsine
C19H17NO4 (323.11575220000003)
Gravacridonol
C19H17NO4 (323.11575220000003)
Romucosine
C19H17NO4 (323.11575220000003)
2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine
C19H21N3S (323.14561060000005)
1-(Isopropyl(dimethyl)-lambda~5~-azanyl)-3-(1-naphthyloxy)-2-propanol
Metiapine
C19H21N3S (323.14561060000005)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
2-(2-Piperidin-1-ylethoxy)benzaldehyde
C16H21NO6 (323.13688060000004)
tert-butyl 4-(5-nitropyridin-2-yl)oxypiperidine-1-carboxylate
1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID
C17H22FNO4 (323.15327840000003)
METHYL 2-METHYL-8-OXO-3-PHENYL-5,6,7,8-TETRAHYDRO-1-OXA-7A-AZAINDACENE-4-CARBOXYLATE
C19H17NO4 (323.11575220000003)
tert-butyl 4-(3-nitropyridin-2-yl)oxypiperidine-1-carboxylate
Mepixanox
C20H21NO3 (323.15213560000007)
R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent
(1r,2r)-2-(naphthalene-2,3-dicarboximido)cyclohexanecarboxylic acid
C19H17NO4 (323.11575220000003)
4-(TERT-BUTOXYCARBONYL(4-METHOXYBENZYL)AMINO)BUTANOIC ACID
(4-ISOPROPYLPHENYL)(2-NITRO-5-(PROP-2-YNYLOXY)PHENYL)METHANONE
C19H17NO4 (323.11575220000003)
2-N-BOC-3-(4-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID
2-N-BOC-3-(3-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID
Boc-L-aspartic acid 4-benzyl ester
C16H21NO6 (323.13688060000004)
boc-(r)-alpha-(4-fluorobenzyl)-proline
C17H22FNO4 (323.15327840000003)
(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-fluorobenzyl)pyrrolidine-2-carboxylic acid
C17H22FNO4 (323.15327840000003)
METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-METHOXY-PHENYL)-PROPIONATE
(R)-N-Fmoc-Azetidine-2-Carboxylic Acid
C19H17NO4 (323.11575220000003)
1-BOC-4-(4-CHLOROBENZOYL)PIPERIDINE
C17H22ClNO3 (323.1288132000001)
Renzapride
Renzapride (BRL 24924), a substituted benzamide, is a full 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride (BRL 24924) is also a 5HT2b and 5HT3 receptor antagonist[1]. Renzapride could be used for constipation predominant irritable bowel syndrome (C-IBS) study[2].
(2S)-1-(9H-fluoren-9-ylmethoxycarbonyl)azetidine-2-carboxylic acid
C19H17NO4 (323.11575220000003)
(S)-5-GUANIDINO-2-(4-NITROBENZAMIDO)PENTANOIC ACID
N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide
C19H22BNO3 (323.16926520000004)
N5-(1-CYCLOHEPTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL)PYRIDINE-2,5-DIAMINE
ethyl 5,5,5-trifluoro-4-naphthalen-1-yliminopentanoate
(2S)-2-phenyl-2-[[(1S)-1-[4-(trifluoromethyl)phenyl]propyl]amino]ethanol
C18H20F3NO (323.14969060000004)
N-(2,5-Dimethoxyphenyl)-3-hydroxy-2-naphthamide
C19H17NO4 (323.11575220000003)
boc-(s)-alpha-(4-fluorobenzyl)-proline
C17H22FNO4 (323.15327840000003)
N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide
C15H22BNO4S (323.13625220000006)
H-Ala-Tyr-Ala-OH
N-(3-HYDROXY-4,7,7-TRIMETHYL-BICYCLO[2.2.1]HEPT-2-YL)-4-METHYL-BENZENESULFONAMIDE
C17H25NO3S (323.15550600000006)
Fmoc-1-aminocyclopropane-1-carboxylic acid
C19H17NO4 (323.11575220000003)
(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID
C17H22FNO4 (323.15327840000003)
(3R,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID
C17H22FNO4 (323.15327840000003)
METHYL (2S,5R)-1-CBZ-5-HYDROXY-6-METHOXYPIPECOLINATE
C16H21NO6 (323.13688060000004)
N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-4-pyrazolyl)butane-1-sulfonamide
C15H21N3O3S (323.13035560000003)
(4-(4-Aminoquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone
TERT-BUTYL 6-(BENZYLOXY)-1H-INDOLE-1-CARBOXYLATE
C20H21NO3 (323.15213560000007)
2-fluoro-4-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]benzoic acid
C17H22FNO4 (323.15327840000003)
2-[3-(2H-Benzotriazol-2-yl)-4-hydroxyphenyl]ethyl methacrylate
C18H17N3O3 (323.12698520000004)
TRANS-METHYL 1-(METHYLSULFONYL)SPIRO[CYCLOHEXANE-1,3-INDOLINE]-4-CARBOXYLATE
5-(PIPERIDINE-1-SULFONYL)-2-PIPERIDIN-1-YL-PHENYLAMINE
(9H-FLUOREN-9-YL)METHYL 3-HYDROXYPIPERIDINE-1-CARBOXYLATE
C20H21NO3 (323.15213560000007)
3-[2-(1-PIPERIDINYL)ETHOXY]BENZALDEHYDE OXALATE
C16H21NO6 (323.13688060000004)
(1s,2s)-2-(naphthalene-2,3-dicarboximido)cyclohexanecarboxylic acid
C19H17NO4 (323.11575220000003)
(R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate
C17H22ClNO3 (323.1288132000001)
4-(Phenylaminocarbonyl)benzeneboronic acid pinacol ester
C19H22BNO3 (323.16926520000004)
[4-(6-aminopurin-9-yl)-2-ethoxy-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol
Cinnamaverine
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
3-hydroxy-N-(1-methylpyrazol-3-yl)-5-phenylmethoxybenzamide
C18H17N3O3 (323.12698520000004)
methyl 1-[(4-methoxyphenyl)methyl]-4-oxoquinoline-3-carboxylate
C19H17NO4 (323.11575220000003)
9H-fluoren-9-ylmethyl (3R)-3-hydroxypiperidine-1-carboxylate
C20H21NO3 (323.15213560000007)
9H-fluoren-9-ylmethyl (3S)-3-hydroxypiperidine-1-carboxylate
C20H21NO3 (323.15213560000007)
Methyl (1R,2R)-2-[(4-amino-4-biphenylyl)carbonyl]cyclopentanecar boxylate
C20H21NO3 (323.15213560000007)
2-[3-(3-hydroxyphenyl)-2,3-dimethylpiperidin-1-yl]-1-phenylethanone
5-(tetrahydro-2H-pyran-4-yloxy)pyridine-3-boronic acid pinacol ester
5-AMINOMETHYL-2-(N,N-DITERT-BUTOXYCARBONYLAMINO)PYRIDINE
(S)-tert-Butyl 2-(benzyloxycarbonylamino)-5-hydroxypentanoate
Boc-D-Aspartic acid 4-benzyl ester
C16H21NO6 (323.13688060000004)
3-(4-(Trifluoromethyl)phenoxy)-N,N-dimethyl-3-phenylpropan-1-amine
C18H20F3NO (323.14969060000004)
4-(1,1-Dioxido-2-isothiazolidinyl)phenylboronic Acid Pinacol Ester
C15H22BNO4S (323.13625220000006)
11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine
C19H21N3S (323.14561060000005)
N,N-bis(trimethylsilyl)aminopropyltrimethoxysilane
POLY((ISOBUTYLENE-ALT-MALEIC ACID AMMO&
C19H17NO4 (323.11575220000003)
2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine
1-Benzoyl-4-benzylpiperidine-4-carboxylic acid
C20H21NO3 (323.15213560000007)
4-hydroxy-1-methyl-7-phenoxy-3-Isoquinolinecarboxylic acid ethyl ester
C19H17NO4 (323.11575220000003)
3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester
7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER
C19H17NO4 (323.11575220000003)
tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate
C20H21NO3 (323.15213560000007)
1-(4-FLUOROPHENYL)-4-ISOPROPYL-2-PHENYL-1H-PYRROLE-3-CARBOXYLICACID
C20H18FNO2 (323.13214999999997)
tert-Butyl (2R)-N-(2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl)carbamate
ethyl 2-oxo-2-(5-phenylmethoxy-1H-indol-3-yl)acetate
C19H17NO4 (323.11575220000003)
4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine
C16H23BClNO3 (323.14594280000006)
1-(9H-fluoren-9-ylmethoxycarbonyl)azetidine-2-carboxylic acid
C19H17NO4 (323.11575220000003)
N-[cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide
C14H21N5O2S (323.14158860000003)
D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AH - Agents for dermatitis, excluding corticosteroids C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Remetinostat
C16H21NO6 (323.13688060000004)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-
1H-Imidazole-4-carboxamide, 1-((1R,2S)-2-hydroxy-1-(2-(1-naphthalenyl)ethyl)propyl)-
Tolmicen
C20H21NOS (323.13437760000005)
D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Tolciclate
C20H21NOS (323.13437760000005)
D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents
2-[2-[[2-Amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoylamino]propanoic acid
C11H22N3O6P (323.12461620000005)
1-Amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile
(E)-N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-3-(4-fluorophenyl)prop-2-enamide
2-[(E)-2-(dimethylamino)ethenyl]-3-nitro-1-phenylindol-6-ol
C18H17N3O3 (323.12698520000004)
(5-Hydroxy-2-phenyl-3-benzofuranyl)-(4-morpholinyl)methanone
C19H17NO4 (323.11575220000003)
N-(1,3-benzodioxol-5-ylmethyl)-3,5-dimethyl-2-benzofurancarboxamide
C19H17NO4 (323.11575220000003)
[1-(5-Hydroxypentyl)indol-3-yl]-(4-hydroxyphenyl)methanone
C20H21NO3 (323.15213560000007)
1,5-Naphthyridine-3-carboxamide, 6-ethoxy-1,4-dihydro-4-oxo-N-(phenylmethyl)-
C18H17N3O3 (323.12698520000004)
5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol
4-Piperidino-6-trifluoromethyl-2-(2-hydroxyphenyl)pyrimidine
(6s)-2-Amino-6-(3-Methoxybiphenyl-3-Yl)-3,6-Dimethyl-5,6-Dihydropyrimidin-4(3h)-One
1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide
Ritodrinium
C17H22ClNO3 (323.1288132000001)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Ritodrine (DU21220) hydrochloride is a potent and orally active β-adrenergic agonist. Ritodrine hydrochloride decreases preterm delivery and uterine contraction. Ritodrine hydrochloride has the potential for the research of preterm labor[1][2].
Renzaprida
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists
AIDS-161807
C19H17NO4 (323.11575220000003)
2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-3-hydroxypropanoic acid
10-Hydroxy-2,9-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one
C19H17NO4 (323.11575220000003)
2-Hydroxy-9,10-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one
C19H17NO4 (323.11575220000003)
Akuammicine(1+)
C20H23N2O2+ (323.17594379999997)
An ammonium ion that is the conjugate acid of akuammicine, arising from the protonation of the tertiary amino group.
(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(2,4-diaminobutyl)oxolane-3,4-diol
(2S,3R,4R)-2-azaniumyl-4-(carbamoyloxymethyl)-7-carboxy-3-hydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indol-5-olate
(2S,3R,4R)-2-amino-4-(carbamoyloxymethyl)-3,5-dihydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid
(2S,3R,4S)-2-azaniumyl-4-(carbamoyloxymethyl)-7-carboxy-3-hydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indol-5-olate
(2S,3R,4S)-2-amino-4-(carbamoyloxymethyl)-3,5-dihydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid
(2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoate
3-[3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]propanoic acid
2-[[3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]amino]acetic acid
2-(4-Ethoxyanilino)-3-methoxynaphthalene-1,4-dione
C19H17NO4 (323.11575220000003)
1-[3-[(8-methyl-5H-pyrimido[5,4-b]indol-4-yl)amino]propyl]-2-pyrrolidinone
10-(4-methoxyphenyl)-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione
C20H21NO3 (323.15213560000007)
2-phenoxyacetic acid (8-methyl-2-oxo-1H-quinolin-3-yl)methyl ester
C19H17NO4 (323.11575220000003)
1-[(1,2-Dimethyl-5-indolyl)methyl]-3-(phenylmethyl)thiourea
C19H21N3S (323.14561060000005)
N-(4-methoxyphenyl)-5-(phenoxymethyl)furan-2-carboxamide
C19H17NO4 (323.11575220000003)
N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide
N,N-diethyl-4-[oxo-(2,4,6-trimethylphenyl)methyl]benzamide
2-(3-amino-3-oxopropyl)-3-(4-methylbenzoyl)-2H-indazole 1-oxide
C18H17N3O3 (323.12698520000004)
1-ethyl-2-hydroxy-4-oxo-N-(pyridin-3-ylmethyl)quinoline-3-carboxamide
C18H17N3O3 (323.12698520000004)
2-(2,3-dimethylphenoxy)-N-(2-oxo-1-benzopyran-6-yl)acetamide
C19H17NO4 (323.11575220000003)
8-(Diethylaminomethyl)-7-hydroxy-4-phenyl-1-benzopyran-2-one
C20H21NO3 (323.15213560000007)
N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-methyl-4-pyridinecarboxamide
C18H17N3O3 (323.12698520000004)
1-Pyrrolidinyl-[5-(6-quinolinyloxymethyl)-3-isoxazolyl]methanone
C18H17N3O3 (323.12698520000004)
N-(2-hydroxyethyl)-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide
C18H17N3O3 (323.12698520000004)
3-{[(E)-(2,4-dihydroxyphenyl)methylidene]amino}-2-propylquinazolin-4(3H)-one
C18H17N3O3 (323.12698520000004)
1-(1,3-Benzodioxol-5-yl)-2-(1,2-dihydroimidazo[1,2-a]benzimidazol-4-yl)ethanol
C18H17N3O3 (323.12698520000004)
2,2,7,7,9,9-hexamethyl-10-oxido-8H-pyrano[2,3-b]carbazol-10-ium
5,5-dimethyl-2-[(5-methyl-4-phenyl-1H-pyrazol-3-yl)iminomethyl]cyclohexane-1,3-dione
(1S,12S,14R,15E)-15-ethylidene-17-methyl-3-aza-17-azoniapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylic acid
C20H23N2O2+ (323.17594379999997)
5-(Diethoxymethyl)-3-[(diethoxyphosphinyl)methyl]-2-isoxazoline
2-Deamino-2-hydroxyneamine
An amino cyclitol glycoside that is 2-deoxystreptamine in which the pro-R hydroxy group is substituted by a 6-amino-6-deoxy-alpha-D-glucosyl residue.
methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate
3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline
C20H21NO3 (323.15213560000007)
(S)-stylopine
C19H17NO4 (323.11575220000003)
A berberine alkaloid isolated from the plants of the family papaveraceae.
(S)-Renzapride
(S)-Renzapride ((S)-BRL 24924) is the isomer of HY-14147 Renzapride. Renzapride is a 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride also is a 5HT2b and 5HT3 receptor antagonist. Renzapride can be used for constipation predominant irritable bowel syndrome (C-IBS) study[1][2].
Cbz-Asn-Gly-OH
Cbz-Asn-Gly-OH is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development[1].
(1s,12s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene
C19H17NO4 (323.11575220000003)
15-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-16-ol
C19H17NO4 (323.11575220000003)
(3r)-3-(4-methoxy-5-methyl-6-oxopyran-2-yl)butyl (2r)-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate
C16H21NO6 (323.13688060000004)
1-{5-hydroxy-2,8,8-trimethyl-9h,10h,11h-phenanthro[3,4-d][1,3]oxazol-4-yl}ethanone
C20H21NO3 (323.15213560000007)
(3s,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol
7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
2-{[(4-butanoyl-3-methoxy-5-methylphenyl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid
C16H21NO6 (323.13688060000004)
5-hydroxy-6-methyl-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one
11-hydroxy-3,10-dimethoxy-7,8-dihydro-6-azatetraphen-2-one
C19H17NO4 (323.11575220000003)
(6z)-5-hydroxy-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1h-pyrazine-2,3-dione
C18H17N3O3 (323.12698520000004)
6,7-dimethoxy-1-(4-methoxybenzoyl)isoquinoline
C19H17NO4 (323.11575220000003)
2-(hydroxymethyl)-6-[3-(methoxymethyl)indol-1-yl]oxane-3,4,5-triol
C16H21NO6 (323.13688060000004)
5,10-dihydroxy-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one
C19H17NO4 (323.11575220000003)
5-methyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl acetate
C16H21NO6 (323.13688060000004)
(2-{9-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine
C20H21NO3 (323.15213560000007)
(2s)-2-[(4-aminophenyl)formamido]-3-(1h-indol-3-yl)propanoic acid
C18H17N3O3 (323.12698520000004)
n-[1-(4,5-dihydroxy-6-methyloxan-2-yl)-2-hydroxypyrimidin-4-ylidene]-3-methylbut-2-enamide
n-[4-(benzoyloxy)butyl]-3-phenylprop-2-enimidic acid
C20H21NO3 (323.15213560000007)
5-hydroxy-6-{[2-(2-methylbut-3-en-2-yl)indol-3-ylidene]methyl}-1,4-dihydropyrazine-2,3-dione
C18H17N3O3 (323.12698520000004)
(2r)-5-hydroxy-11-methyl-2-[(2s)-2-methyloxiran-2-yl]-1h,2h-furo[2,3-c]acridin-6-one
C19H17NO4 (323.11575220000003)
5-hydroxy-2-(2-hydroxypropan-2-yl)-11-methylfuro[2,3-c]acridin-6-one
C19H17NO4 (323.11575220000003)
(1r,12r)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene
C19H17NO4 (323.11575220000003)
(2s,3r,4s,5s,6r)-2-[(3-ethyl-1h-indol-4-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
C16H21NO6 (323.13688060000004)
2-[(4-aminophenyl)formamido]-3-(1h-indol-3-yl)propanoic acid
C18H17N3O3 (323.12698520000004)
(1s,12r)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene
C19H17NO4 (323.11575220000003)
16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-17-ol
C19H17NO4 (323.11575220000003)
4-({2-imino-4-[(4-methoxyphenyl)methyl]-3-methylimidazol-1-yl}methyl)phenol
11-hydroxy-3,4-dimethoxy-7,8-dihydro-6-azatetraphen-10-one
C19H17NO4 (323.11575220000003)
8,10-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole
C20H21NO3 (323.15213560000007)
2-methyl-1-(6-methylheptyl)-9h-carbazole-3,4-dione
1-[(9s)-16-hydroxy-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]propan-1-one
C20H21NO3 (323.15213560000007)
8,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one
C19H17NO4 (323.11575220000003)
2-methyl-1-(5-methylheptyl)-9h-carbazole-3,4-dione
1-[(12r)-16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone
C19H17NO4 (323.11575220000003)
7,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one
C19H17NO4 (323.11575220000003)
4-methoxy-3-methyl-6-[9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one
C20H21NO3 (323.15213560000007)
1-{16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethanone
C19H17NO4 (323.11575220000003)
3-hydroxy-4,11-dimethoxy-7,8-dihydro-6-azatetraphen-10-one
C19H17NO4 (323.11575220000003)
n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpentanamide
6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}piperazine-2,3,5-trione
C18H17N3O3 (323.12698520000004)
(1s,4s,4ar,7r)-7-hydroxy-1-isopropyl-4-isothiocyanato-4,7-dimethyl-3,4a,5,6-tetrahydro-2h-naphthalene-1-carboxylic acid
C17H25NO3S (323.15550600000006)
(1r,5s,16s)-5-methyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl acetate
C16H21NO6 (323.13688060000004)
(2s,6r)-2-methoxy-3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),3,8,10-tetraen-12-ol
C20H21NO3 (323.15213560000007)
(3s)-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol
7-methoxy-4-(5-phenylpentyl)-1h-indole-2,3-dione
C20H21NO3 (323.15213560000007)
4-[(6e,8z)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
4-(2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
1-[(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone
C20H21NO3 (323.15213560000007)
(2s)-1-[(3-acetyl-2-hydroxy-4,6-dimethoxyphenyl)methyl]pyrrolidine-2-carboxylic acid
C16H21NO6 (323.13688060000004)
1-(3,3-dimethyloxiran-2-yl)-5-methoxy-1h,6h-furo[3,4-c]carbazol-3-one
C19H17NO4 (323.11575220000003)
(2s)-2-{[(4-butanoyl-3-methoxy-5-methylphenyl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid
C16H21NO6 (323.13688060000004)
(2-{10-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine
C20H21NO3 (323.15213560000007)
(2r,3r,4r)-2,3,4,5-tetrahydroxypentyl (2s)-2-(1h-indol-3-yl)propanoate
C16H21NO6 (323.13688060000004)
3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol
(2e)-n-{4-[(e)-benzoyloxy]butyl}-3-phenylprop-2-enimidic acid
C20H21NO3 (323.15213560000007)
8,9-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole
C20H21NO3 (323.15213560000007)
methyl (4ar,7ar)-7-(hydroxymethyl)-2-(4-methoxy-4-oxobutyl)-1-oxo-4ah,5h,7ah-cyclopenta[c]pyridine-4-carboxylate
C16H21NO6 (323.13688060000004)
(3r,6e)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol
6,7,8,13-tetramethoxy-2-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-1,3,5,7,9(16),10,12,14-octaene
C19H17NO4 (323.11575220000003)
methyl 7-(hydroxymethyl)-2-(4-methoxy-4-oxobutyl)-1-oxo-4ah,5h,7ah-cyclopenta[c]pyridine-4-carboxylate
C16H21NO6 (323.13688060000004)
3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene
C20H21NO3 (323.15213560000007)
(2r)-5-hydroxy-11-methyl-2-[(2r)-2-methyloxiran-2-yl]-1h,2h-furo[2,3-c]acridin-6-one
C19H17NO4 (323.11575220000003)
methyl (12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene-11-carboxylate
C19H17NO4 (323.11575220000003)
1-[(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone
C20H21NO3 (323.15213560000007)
(1r)-1-[(2s)-3,3-dimethyloxiran-2-yl]-5-methoxy-1h,6h-furo[3,4-c]carbazol-3-one
C19H17NO4 (323.11575220000003)
methyl 1-methoxy-4-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carboxylate
C20H21NO3 (323.15213560000007)
n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpentanamide
5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15(23),16(20),21-hexaene
C19H17NO4 (323.11575220000003)
4-methoxy-3-methyl-6-[(2e,4e,6e,8e)-9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one
C20H21NO3 (323.15213560000007)
23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene
C19H17NO4 (323.11575220000003)
4-({2-imino-5-[(4-methoxyphenyl)methyl]-3-methyl-1h-imidazol-4-yl}methyl)phenol
(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene]amino}-1-hydroxypropylidene]amino}propanoic acid
C11H22N3O6P (323.12461620000005)
(1s,4s,5r,6s,7r,17s)-7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione
(12r)-17-methoxy-11,18-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene
C20H21NO3 (323.15213560000007)
n-{1-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbut-2-enamide
1-{15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl}ethanone
C20H21NO3 (323.15213560000007)
1-hydroxy-3-methoxy-10-methyl-4-(3-methylbut-2-en-1-yl)acridin-9-one
C20H21NO3 (323.15213560000007)
4-[(2r,5r,6e,8e)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
4-[(2r,5e,7e)-2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
4-(2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one
1-hydroxy-3-methoxy-10-methyl-2-(3-methylbut-2-en-1-yl)acridin-9-one
C20H21NO3 (323.15213560000007)
2-[(2-hydroxy-3,4-dihydroquinolin-8-yl)oxy]-5-methoxy-6-methyloxane-3,4-diol
C16H21NO6 (323.13688060000004)
(3r,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol
4,5-bis[(4-methoxyphenyl)methyl]-1,3-dihydroimidazol-2-imine
2-methyl-1-[(5s)-5-methylheptyl]-9h-carbazole-3,4-dione
23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene
C19H17NO4 (323.11575220000003)
(2r)-5-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-11-methyl-1h,2h-furo[2,3-c]acridin-6-one
C19H17NO4 (323.11575220000003)
2,3,4,5-tetrahydroxypentyl 2-(1h-indol-3-yl)propanoate
C16H21NO6 (323.13688060000004)